Focus on synthesis of complex API and its intermediates
Omgene is a Vadodara based R&D stage company engaged in development of lab-scale
quantities of peptides, semi-synthetic & synthetic APIs and its intermediates
Expertise in synthesizing long peptide chains – up to 40 amino acid chains
Formulation R&D facility for complex generics
Qualified Scientists and Team Leaders to support development of Complex generics
GMP1 Commercial Manufacturing facility
Cleanroom facility within existing premises for supply of small volume API quantities:
Initiated manufacturing of 8 peptide APIs and 2 semi synthetics API from August 2022
(FY23) FDA Approval is available.
Quality Assurance Facility
Quality Control Facility
Established in 2011, as a private limited company registered under Companies Act, 1956, we
are quickly growing towards creating a vast impact on the healthcare industry.